MetLife secures last-minute Real Value of $56.1572 per share. The latest price of the firm is $48.81. At this time the firm appears to be undervalued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Return On Equity of
9.12%, Profit Margin of 7.56% and Current Valuation of 117.05B as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
June 18, 2019
MetLife is very steady asset. Calculation of real value of MetLife is based on 2 months time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Valuation Drivers Correlation
|Click cells to compare fundamentals||View All Correlations|
MetLife Market CapMetLife is considered to be number one stock in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 96.94 Billion. MetLife totals roughly 43.92 Billion in market capitalization claiming about 45% of equities under Insurance - Life industry.
|Horizon||30 Days Login to change|
MetLife is regarded second in last dividend paid category among related companies. It is rated below average in price to sales category among related companies fabricating about 0.36 of Price to Sales per Last Dividend Paid. The ratio of Last Dividend Paid to Price to Sales for MetLife is roughly 2.79
|Last Dividend Paid|
|Price to Sales ( times )|